Marketing - Press Releases

Date	Title	Company
04-Aug-2020	The new Marketplace for Pharma Business Opportunities is now online	Raucon
03-Aug-2020	Insilico Biotechnology AG reports progress on the use of methanol for the sustainable production of fine chemicals	Insilico Biotechnology AG
03-Aug-2020	UCL Technology Fund announces first close of £100m Fund 2	UCL Technology Fund
03-Aug-2020	Enterome scientists contribute to extensive new genomic and proteomic catalog to enhance analysis of the gut microbiome and understanding of its role in human health	ENTEROME SA,
03-Aug-2020	Novartis Cosentyx® receives EU approval for first-line systemic treatment in pediatric psoriasis	Novartis
03-Aug-2020	ASLAN PHARMACEUTICALS APPOINTS KENNETH KOBAYASHI, MD, AS CHIEF MEDICAL OFFICER	ASLAN Pharmaceuticals
03-Aug-2020	Lilly Initiates Phase 3 Trial of LY-CoV555 for Prevention of COVID-19 at Long-Term Care Facilities in Partnership with the National Institute of Allergy and Infectious Diseases (NIAID)	Eli Lilly
31-Jul-2020	CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched	CPhI Japan
31-Jul-2020	Pharmapack Europe moves to May 2021	Pharmapack Europe
31-Jul-2020	Novadip Biosciences to Present at the LifeSci Partners Summer Symposium	Novadip Biosciences
31-Jul-2020	AMRYT TO HOST KEY OPINION LEADER CALL ON EPIDERMOLYSIS BULLOSA DISEASE LANDSCAPE	Amryt
31-Jul-2020	Enterome initiates first clinical trial with EO2401 – an innovative microbiome-antigen (‘OncoMimic’) based cancer immunotherapy candidate targeting aggressive brain cancer	Enterome
31-Jul-2020	Tagrisso granted Breakthrough Therapy Designation in the US for the adjuvant treatment of patients with Stage IB-IIIA EGFR-mutated lung cancer	AstraZeneca
31-Jul-2020	BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo® (cemiplimab) Combination in Melanoma	BioNTech
31-Jul-2020	Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate	Pfizer Inc
30-Jul-2020	Chi-Med Reports 2020 Interim Results and Provides Updates on Key Clinical Programs	Chi-Med
30-Jul-2020	Oculis to Present at the LifeSci Partners Private Company Virtual Summer Symposium	Oculis
30-Jul-2020	New data in NEJM shows nirsevimab reduced respiratory syncytial virus infections (lower respiratory tract infections) requiring medical care in healthy premature infants	sanofi
30-Jul-2020	Acacia Pharma Advances Preparations for US Launch of BARHEMSYS®	Acacia Pharma Group plc
30-Jul-2020	Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications	Oculis